*7.5 Contact Hours* Get ready to bolster your peds pharm knowledge! How familiar are you with cannabis hyperemesis syndrome, a newer issue increasing affecting adolescents? How do you tailor primary care for children receiving biologics / immunomodulators? This module covers an extensive list of medication topics to support your practice:
- Evidence-based pharmacologic management of constipation
- Established and existing pharmacologic management of asthma, seizure disorders, type I and type II diabetes mellitus (including newer insulin delivery systems), rheumatologic diseases, and cannabis hyperemesis syndrome
- Mechanism of action for selected anti-epileptic and diabetes medications
- Adverse effects of immunomodulatory agents used for inflammatory bowel disease, asthma and rheumatologic disorders; inhaled corticosteroids and beta-agonists for asthma; metformin and insulins for diabetes
- Tailoring primary care for children receiving biologics / immunomodulators; monitoring for children receiving these therapies plus others such as methotrexate and inhaled corticosteroids
- Recognition and management of common and uncommon, benign and serious cutaneous medication reactions
- Legislation and regulatory directives affecting development and approval of pediatric medications, includes discussion of off-label use (historical and current)
